- Cart - 0 item(s)
- $0.00
Your shopping cart is empty!
- Chemistry
- Bioactive Molecules
- Anti-infection
- Apoptosis
- Autophagy
- Cell Cycle/DNA Damage
- Cytoskeleton
- Epigenetics
- GPCR/G Protein
- Immunology/Inflammation
- JAK/STAT Signaling
- MAPK/ERK Pathway
- Membrane Transporter/Ion Channel
- Metabolic Enzyme/Protease
- Neuronal Signaling
- NF-κB
- PI3K/Akt/mTOR
- PROTAC
- Protein Tyrosine Kinase/RTK
- Stem Cell/Wnt
- TGF-beta/Smad
- Vitamin D Related/Nuclear Receptor
- Others
- Methylation
- Cytoskeletal Signaling
- Natural Products
- Alkaloids
- Amino acid
- Anthraquinones
- Cerebrosides
- Chalcones
- Coumarins
- Diterpenoids
- Flavonoids
- Iridoids
- Lignans
- Lipids
- Miscellaneous
- Monoterpenoids
- Other terpenes
- Phenols
- Phenylpropanoids
- Quinones
- Saccharides
- Sesquiterpenoids
- Steroids
- Tetraterpenoids
- Thiophenes
- Triterpenoids
- Xanthones
- Polyphenols
- Stibene glucosides
- Oligose
- Anthocyanins
- Miscellaneous
- Chromones
- Terpenoids
- Indoles
- Procyanidins
- Aliphatics
- Botanical Cyclopeptides
- ADCs
- Antibodies
- Multiplex IHC
- Material Science
- Others
[CAS NO. 1952272-74-0] Bemarituzumab
| Ships within | Stock | Price | Qty | Total |
Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.
| Catalog: | HY-P99010 |
| Brand: | MCE |
| CAS: | 1952272-74-0 |
Overview
| MDL | - |
|---|---|
| Molecular Weight | - |
| Molecular Formula | - |
| SMILES | [Bemarituzumab] |
Summary
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date | Phase |
|---|---|---|---|---|
| NCT03694522 | Five Prime Therapeutics, Inc.|Zai Lab (Shanghai) Co., Ltd. |
Gastric Cancer
|
September 14, 2018 | Phase 2 |
| NCT05322577 | Amgen |
Gastric Cancer|Gastroesophageal Junction Cancer
|
May 17, 2022 | Phase 1 |
| NCT05325866 | Amgen |
Solid Tumors
|
September 23, 2022 | Phase 1 |
| NCT05111626 | Amgen |
Gastric Cancer|Gastroesophageal Junction Adenocarcinoma
|
March 14, 2022 | Phase 3 |
| NCT02213289 | University of Chicago|AbbVie |
Adenocarcinoma
|
January 20, 2015 | Phase 2 |
| NCT05052801 | Amgen |
Gastric Cancer|Gastroesophageal Junction Adenocarcinoma
|
March 7, 2022 | Phase 3 |
| NCT05267470 | Amgen |
Squamous-Cell Non-Small-Cell Lung Cancer
|
March 29, 2022 | Phase 1 |
Appearance
Liquid
Shipping
Shipping with dry ice.
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.